✦ LIBER ✦

Corrigendum: Mutations in NR4A2 associated with familial Parkinson disease

✍ Scribed by Le, W ;Xu, P ;Jankovic, J ;Jiang, H ;Appel, S H ;Smith, R G ;Vassilatis, D K

Book ID: 109915039
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 35 KB
Volume: 33
Category: Article
ISSN: 1061-4036
DOI: 10.1038/ng0203-214

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in NR4A2 associated with famil

Mutations in NR4A2 associated with familial Parkinson disease

✍ Le, Wei-dong; Xu, Pingyi; Jankovic, Joseph; Jiang, Hong; Appel, Stanley H.; Smit 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 644 KB

NR4A2 mutations are rare among European

NR4A2 mutations are rare among European patients with familial Parkinson's disease

✍ Claudia Wellenbrock; Katja Hedrich; Nora Schäfer; Meike Kasten; Helfried Jacobs; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

Molecular biology changes associated wit

Molecular biology changes associated with LRRK2 mutations in Parkinson's disease

✍ Yi Wei Lu; Eng-King Tan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract Parkinson's disease (PD) is characterized by progressive dopaminergic neuronal loss in the substantia nigra. The recent discovery of __leucine‐rich‐repeat kinase 2__ gene (__LRRK2__) mutations in PD is significant because these mutations are the most common cause of autosomal dominant P

LRRK2 G2019S mutations are associated wi

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

✍ Rachel Saunders-Pullman; Matthew J. Barrett; Kaili M. Stanley; Marta San Luciano 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract Leucine rich repeat kinase (__LRRK2__) G2019S mutations are presumed to cause PD through a toxic gain of function of the protein kinase. Small molecule kinase inhibitors have been developed for the treatment of certain cancers, and some antioncogenic agents such as sunitinib, may nonspe

NR4A2 genetic variation in sporadic Park

NR4A2 genetic variation in sporadic Parkinson's disease: A genewide approach

✍ Daniel G. Healy; Patrick M. Abou-Sleiman; Kourosh R. Ahmadi; Sonia Gandhi; Mirat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

## Abstract The __NR4A2__ gene, which may cause autosomal dominant Parkinson's disease (PD), has also been reported to be a susceptibility factor for sporadic PD. Here, we use a haplotype‐tagging approach in 802 PD patients and 784 controls and demonstrate that common genetic variation, including _

Occurrence of a mutation associated with

Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease

✍ C. L. Maslen; D. Babcock; D. R. Illingworth 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 403 KB